Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) has 239 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 15,759,799 | 1,466,024 | 10.26% | $572,395,895.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 9,040,502 | 4,599,811 | 103.58% | $328,454,390.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 8,478,815 | 490,267 | 6.14% | $307,950,573.00 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 31 Mar, 2026 | 8,338,098 | 1,405,000 | 20.27% | $302,839,719.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 8,157,204 | 119,315 | 1.48% | $296,269,650.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 6,395,922 | 8,182 | 0.13% | $232,299,887.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 5,355,496 | 5,355,496 | 0.00% | $194,513.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,673,935 | 4,673,935 | 0.00% | $169,757,319.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,638,511 | 4,638,511 | 0.00% | $168,470,720.00 |
| EcoR1 Capital, LLC | 31 Mar, 2026 | 4,288,120 | 0 | 0.00% | $155,744,518.00 |
| Bellevue Group AG | 31 Mar, 2026 | 3,280,000 | 3,275,960 | 81,088.12% | $119,129,600.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,480,763 | 238,132 | 10.62% | $90,119,429.00 |
| State Street Corp | 31 Mar, 2026 | 2,403,046 | 241,668 | 11.18% | $87,278,631.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 2,351,465 | 702,596 | 42.61% | $85,405,209.00 |
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 1,940,622 | 1,852,416 | 2,100.10% | $70,484.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 1,903,636 | 396,000 | 26.27% | $69,140,060.00 |
| Pictet Asset Management Holding SA | 31 Mar, 2026 | 1,884,281 | 323,981 | 20.76% | $68,204,218.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Mar, 2026 | 1,716,445 | 389,063 | 29.31% | $62,341,282.00 |
| GW&K Investment Management, LLC | 31 Mar, 2026 | 1,618,686 | 142,361 | 9.64% | $58,791.00 |
| Novo Holdings A/S | 31 Mar, 2026 | 1,550,000 | -75,000 | -4.62% | $56,296,000.00 |